Viral Hepatitis A Prevention
Prevention of hepatitis A includes:
- Vaccination for hepatitis A:
- For those who travel to underdeveloped nations
- For those who practice anal sex
- For those who abuse intravenous drugs
- For those who have hepatitis B or hepatitis C
- Wash hands after using the bathroom.
- Wash hands after changing diapers.
- Immune globulin for hepatitis A:
- For those who have close contact with a person infected with hepatitis A
Viral Hepatitis A Vaccine
- Vaqta Paediatric
Indications for Hepatitis A Vaccine
- Persons 2 years of age and older traveling to or working in countries with high or intermediate prevalence of hepatitis A, such as those located in Central or South America, the Caribbean, Mexico, Asia (except Japan), Africa, and eastern Europe.
- Children and adolescents who live in states or communities where routine vaccination has been recommended.
- Men who have sex with men.
- Persons who use street drugs.
- Persons with chronic liver disease.
- Persons who are treated with clotting factor concentrates.
- Those traveling to an area where hepatitis A is common.
Anyone who moderately or severely ill at the time the shot is scheduled should probably wait until they recover. Ask your doctor or nurse. People with a mild illness can usually get the vaccine.
Primary immunization for adults consists of single dose. Primary immunization for children (2 to 18 years of age) consists of 2 doses, given 1 month apart.
Getting hepatitis A vaccine is much safer than getting the disease.
- Soreness where the shot was given; Minor symptoms can be treated with acetaminophen or ibuprofen. Avoid the use of aspirin in children to reduce the risk of Reye's syndrome.
- Headache (about 1 out of 6 adults and 1 out of 20 children)
- Loss of appetite (about 1 out of 12 children)
- Tiredness (about 1 out of 14 adults)
Continue to Viral Hepatitis A Outlook
- Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis--United States, 2002-2004. MMWR Morb Mortal Wkly Rep. 2005 May 13;54(18):453-6. 
- Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004 Dec;132(6):1005-22. 
- Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs. 2003;63(23):2625-49. 
- Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005 Sep 28;74(1):39-45. 
- Saab S, Lee C, Shpaner A, Ibrahim AB. Seroepidemiology of hepatitis A in patients with chronic liver disease. J Viral Hepat. 2005 Jan;12(1):101-5. 
- Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005 Jul 13;294(2):194-201.